Colorado's FusionPharm to Liquidate and Dissolve
Published: May 04, 2017
LAKEWOOD, CO--(Marketwired - May 3, 2017) - FusionPharm, Inc., (
Pending legal proceedings have made it impossible for the Company to continue operations. Scott Dittman, the Company's remaining sole officer and director, has stepped down from these positions after authorizing the Company's legal counsel to handle the liquidation.
Safe Harbor Statement
This press release may contain forward looking statements which are based on current expectations, forecasts, and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues and any payment of dividends on our common and preferred stock, statements related to our financial performance, expected income, distributions, and future growth for upcoming quarterly and annual periods. Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with OTC Markets.